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Cellular Interactions in Type 2 Cell-Mediated Immune Responses in Allergy
Helminths, venoms, proteases, allergens, and some bacteria and viruses (not shown) induce type 2 reactions via multiple mechanisms (see table), some of which may act in 
parallel or in concert. These responses are highly coordinated through collaboration of innate and adaptive immune cells via secreted cytokines and soluble mediators (not shown). 
Mast cells, basophils, and eosinophils can act as terminal effectors of type 2 cell-mediated immunity but also have the potential to infl uence the development and immunoregula-
tion of the responses (e.g., via interleukin-4 [IL-4]/IL-13 that can enforce T helper 2 [Th2] cell polarization, cause alternatively activated macrophage [AAM] polarization, and activate 
DCs and innate lymphoid cells type 2 [ILC2s]). Upon recognition of type 2 cell stimuli, and instructed by epithelial cells (ECs), conventional DCs type 2 (cDC2s) polarize naive CD4+ 
T cells (CD4n) to become Th2 cells (see panel). One critical function of IL-4/IL-13 is induction of B cell immunoglobulin E (IgE) class switching, a process enhanced by CD40L. Once 
antigen-specifi c IgE is produced, IgE-dependent focused antigen presentation (via FcεRI expressed on DCs, or via CD23 on DCs or B cells, not shown) can result in generation of 
IgE to additional epitopes (“epitope spreading”), contributing to exacerbation of allergic disorders. IL-4/IL-13 also can induce epithelial goblet cell metaplasia, which can contribute to 
parasite expulsion but can cause airway obstruction with mucus in asthma. CD4+ Th2 cells and ILC2s also produce amphiregulin (Areg), which promotes repair of epithelial cells via 
EGFR; this mechanism also might contribute to parasite expulsion.
A CD4+ Th2 cell subset (Th9) produces IL-9 that drives ILC2 expansion and, in mice, proliferation of mast cell progenitors. ILC2s represent important early sources of IL-5 and 
IL-13 in responses to helminths and allergens. ILC2-derived IL-13 promotes the migration and activation of immature DCs, enforcing adaptive type 2 immunity. ILC2 functions are 
boosted by IL-2 (and IL-9) from CD4+ Th2 cells. It is still debated whether, and to what extent, ILC2s, eosinophils, basophils, and mast cells also can act as antigen-presenting cells 
(APCs) in adaptive type 2 immunity in vivo.
Differences and Similarities between Th2 Cells and ILC2
These cells share many functions, but ILC2s don’t express the TCR. Emerging evidence indicates that memory Th2 cells (Th2mem) might most resemble ILC2s in expressing high 
levels of IL-33R and IL-25R, secreting cytokines in the absence of TCR ligation. It is not yet clear to what extent ILC2s also contribute to IgE synthesis.
Epithelial Responses to Type 2 Cell Stimuli
Most allergens and helminths enter the body via skin or mucosal surfaces, and innate responses of ECs at such sites (sometimes infl uenced by genetic or acquired impairments 
of epithelial barrier function) are integral components of elicited type 2 immune responses. Danger signals (like high-mobility group box 1) promote production of cytokines, thymic 
stromal lymphopoietin (TSLP), and/or granulocyte-macrophage colony-stimulating factor (GM-CSF) that stimulate DCs, ILCs, and other innate cells. ECs also produce chemokines 
(e.g., eotaxins and CCL17) that attract type 2 cells via CCR3 and CCR4 receptors.
Eosinophil Functions
Eosinophils produce diverse products with roles in host defense (see fi gure), metabolism, tissue remodeling, and allergic disorders and might also contribute immunoregulatory 
functions. Modern asthma treatments stratify patients into eosinophil-rich or -poor subtypes. 
Mast Cell and Basophil Functions: Similarities and Differences
Mast cells (MCs) normally reside in tissues, especially in the skin and mucosal tissues, whereas basophils (Basos) are circulating granulocytes that are recruited into tissues from 
the blood. MCs and basophils express many high-affi nity IgE receptors (FcεRIs) and can secrete distinct albeit partially overlapping spectra of products when activated by IgE and 
antigen or other mechanisms. Beyond roles in allergic disorders, MCs contribute to innate and adaptive (type 2) immune defenses against venoms, and MCs and basophils are 
thought to collaborate in orchestrating type 2 immune responses that can enhance resistance to certain internal parasites and ticks. Basophil activation tests (BATs) that measure 
increases in surface CD63 or CD203c (in human basophils) after crosslinking of IgE ex vivo are being evaluated to diagnose and monitor allergies.
Type 2 Cell-Mediated Immunity in Metabolism and Fibrosis
Type 2 immune responses are also observed in adipose tissue, e.g., during cold exposure or after exercise-induced release of meteorin-like (Metrnl) hormone and, in general, 
are thought to promote metabolic normalcy. Cold exposure leads to accumulation of eosinophils and ILC2s that can contribute to proliferation of adipocyte progenitors (APs) and 
their differentiation to beige fat, where UCP1 leads to uncoupling of mitochondria and thermogenesis. IL-33 activated ILC2s and eosinophils (via IL-13 and IL-4, respectively) can 
contribute to this process by stimulating alternatively activated macrophage (AAM) differentiation, with ILC2-derived methionine-enkephalin and AAM-derived norepinephrine (NE) 
promoting lipolysis in white fat and thermogenesis in beige adipose tissue.
Eosinophils and AAMs have roles in tissue repair and in diverse fi brotic disorders. AAMs use arginine to produce hydroxyproline (a precursor of collagen) via arginase, thus mov-
ing away from pro-infl ammatory NO production. Eosinophils produce TGF-β that promotes myofi broblast differentiation, together with IL-13 and Areg derived from ILC2s or Th2 cells.
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